19
2022Swordfish Advertising
AGENCY STATEMENT
We are an award-winning, specialist, multi-disciplinary healthcare agency, specialising in strategic and creative brand solutions for pharmaceutical clients in the UK, Europe & Internationally.

- Agency description
We are Swordfish Advertising: an independent, award-winning creative communications agency, specialising in health.
United by our shared desire to improve the landscape of healthcare for patients and professionals alike, we create insight-driven campaigns that change the way people think and act; campaigns that change people’s lives for the better.
We combine expertise in strategy, planning, data, tech and creative, alongside specialisms in science and medicine to deliver innovative solutions that overcome complex healthcare problems. Our teams go above and beyond to set the pace and lead the way, so that our client’s brands thrive and the people they serve do too.
- Contact details
- Royal London Buildings 42-46 Baldwin Street Bristol BS1 1PN
- 0117 9468420
- info@swordfishadvertising.co.uk
- https://www.swordfishadvertising.co.uk/
- Key contact
- John Bohin
- Director
- johnb@swordfishadvertising.co.uk
- 07766331246
- 2022 Agency Data
-
2021 awardsTotal staff25-49 staffBillings from UK creative healthcare workHealthcare staff25-49 staffTotal agency billingsAgency ageBetween 20 and 30 yearsSocial media footprintStatusINDEPENDENTApproximate percentage of advertising, branding, creative or design work in the UK healthcare market70-79%
- This information was supplied or confirmed by Swordfish Advertising. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- Awards
- PMSociety Awards 2022 - Advertising - Sixmo Cutting the ties Crossing - Finalist
PMSociety Awards 2022 - Advertising - Sixmo Cutting the ties Decorator - Finalist
PMSociety Awards 2022 - BRAND CAMPAIGN - Sixmo Cutting the ties brand campaign - Bronze - This may contain additional awards supplied by Swordfish Advertising that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
COVID-19 Updates and Daily News
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
Quick links
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Genmab hires first chief operating officer
- A relentless commitment to neuroscience
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...